Avelos Therapeutics is a synthetic lethality-specialized anti-cancer drug development company currently developing anti-cancer drugs targeting substances involved in DNA damage response, cell cycles, and more
Investors 3
Mentions in press and media 1
| Date | Title | Description | Source |
| 22.08.2022 | Avelos Therapeutics Raises $8M in Series A Funding | Avelos Therapeutics, a Seoul, South Korea-based biotechnology company specializing in new drug disco... | finsmes.co... |